|
|
 |
|
Viewing report
|
|
|
|
2011 Radiotherapy Today and Tomorrow
Frost & Sullivan, Dec 2011, Pages: 49
This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that can treat localized tumors. SRS systems, due to their accuracy and precision, minimize damage to healthy tissue, making them ideal for treatment of complicated tumors located near the brain or spine. This survey is intended to gather qualitative feedback on how radiosurgery centers plan to work around external challenges.
Market Segmentation
The market is segmented based on device capabilities and the robustness of a system. Low-end devices deliver wide-body radiation, whereas higher-end systems offer greater targeting and treatment planning.
Image guided radiotherapy (IGRT) leverages three-dimensional (3D) imaging, including computed tomography (CT) and magnetic resonance imaging (MRI), to provide coordinates for directed tumor treatment. Intensity-modulated radiotherapy (IMRT) leverages computer-controlled linear accelerators that can modify the radiation dose through the volume of a tumor. Stereotactic radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, andradiation delivery components to treat localized tumors. Robot-assisted radiosurgery is an advanced form of stereotactic radiosurgery in which image guidance is used to automate treatment to a greater degree.
Proton beam therapy is a highly precise form of radiation treatment. Proton beam therapy can be focused so that only the tumor itself is irradiated, effectively performing selective cell destruction through ionization. The energized proton particles pass through the cancerous cells, damaging the DNA and destroying the tumor. This precision allows clinicians to more aggressively eliminate cancerous tumors.Due to the high costs of systems, they are seen as highly specialized.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
